普里维亚健康
PRVA
22.52
-0.10
-0.44%
普里维亚健康
US · PRVA
#2604 按市值排名
上市于 2021
22.52
-0.10
-0.44%
实时 - 追踪5344个代码 - 心跳于129秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例下降了0.3个百分点。
机构持股
- 机构持股比例
- 100.10% -0.34pp
- 机构数量
- 359 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund74.69%
Hedge Fund13.77%
VC/PE Fund6.10%
Public Company2.14%
Insurance Company1.60%
Government Pension Fund1.23%
Individual/Insider0.49%
Private Company0.48%
主要股东 截至 2026-06-30
BlackRock
16.76% · 21.40M 股
FMR
10.04% · 12.82M 股
Durable Capital Partners, LP
9.11% · 11.64M 股
Vanguard Portfolio Management, LLC
5.15% · 6.57M 股
Rubicon Founders LLC
5.07% · 6.47M 股
Vanguard Capital Management, LLC
4.70% · 6.00M 股
State Street Global Advisors
3.84% · 4.91M 股
Van Berkom and Associates Inc.
2.91% · 3.71M 股
Geode Capital Management, LLC
2.45% · 3.13M 股
Riverbridge Partners, LLC
2.35% · 3.00M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 12次买入 · 38次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| David Mountcastle | Chief Financial Officer | 0.14% |
| Parth Mehrotra | Chief Executive Officer | 0.11% |
| Matthew Morris | Director | 0.07% |
| Thomas McCarthy | Independent Director | 0.05% |
| David King | Independent Chairperson | 0.03% |
| Jaewon Ryu | Independent Director | 0.03% |
| Nancy Cocozza | Independent Director | 0.03% |
| Pamela Kimmet | Director | 0.02% |
| David Wichmann | Director | 0.01% |
| Edward Fargis | Executive Vice President, General Counsel & Corporate Secretary | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-31 | Opella Ernest | Director | Other Acquisition | +6,350 | -- |
| 2026-07-08 | David Mountcastle | Chief Financial Officer | Automatic Disposition | -21,275 | $27.67 |
| 2026-07-06 | David Mountcastle | Chief Financial Officer | Automatic Disposition | -600 | $27.57 |
| 2026-07-05 | Matthew Morris | Director | Derivative Exercise and Sale | -112,759 | $2.00–27.33 |
| 2026-07-01 | David Mountcastle | Chief Financial Officer | Automatic Disposition | -24,734 | $27.50 |
| 2026-06-30 | Matthew Morris | Director | Derivative Exercise and Sale | -135,498 | $2.00–26.93 |
| 2026-06-28 | Matthew Morris | Director | Derivative Exercise and Sale | -151,322 | $2.00–25.33 |
| 2026-06-25 | David Mountcastle | Chief Financial Officer | Derivative Exercise and Sale | -17,196 | $2.00–25.18 |
| 2026-05-19 | Francis Soistman | Former Independent Director | Other Acquisition | +8,463 | -- |
| 2026-05-19 | Lance Berberian | Independent Director | Other Acquisition | +8,463 | -- |
| 2026-05-19 | Nancy Cocozza | Independent Director | Other Acquisition | +8,463 | -- |
| 2026-05-19 | David King | Independent Chairperson | Other Acquisition | +8,463 | -- |
| 2026-05-19 | Pamela Kimmet | Director | Other Acquisition | +8,463 | -- |
| 2026-05-19 | Matthew Morris | Director | Other Acquisition | +8,463 | -- |
| 2026-05-19 | Thomas McCarthy | Independent Director | Other Acquisition | +8,463 | -- |
| 2026-05-19 | Jaewon Ryu | Independent Director | Other Acquisition | +8,463 | -- |
| 2026-05-11 | Parth Mehrotra | Chief Executive Officer | Open Market Disposition | -121,086 | $22.55–22.64 |
| 2026-05-11 | Parth Mehrotra | Chief Executive Officer | Intent to Sell (Form 144) | -15,647 | $22.64 |
| 2026-05-10 | David Mountcastle | Chief Financial Officer | Open Market Disposition | -3,385 | $22.60 |
| 2026-05-10 | Parth Mehrotra | Chief Executive Officer | Intent to Sell (Form 144) | -91,403 | $22.55 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
普里维亚健康 讨论区 0 条评论